What is Arcutis Biotherapeutics, Inc.'s net debt / EBITDA?

Arcutis Biotherapeutics, Inc. (ARQT) reported net debt / EBITDA of 12.9× in Q2 2024.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.

Arcutis Biotherapeutics, Inc. ARQT Net debt / EBITDA

Net debt / EBITDA at other companies

PfizerPFE

3.8×—

AmgenAMGN

3.7×-0.7×

IncyteINCY

-2×-0.8×

OrganonOGN

6×+0.4×

Ligand PharmaceuticalsLGND

-0.9×—

TG TherapeuticsTGTX

2.1×+0.1×

Other financials

Income statement

See full

Revenue$105.4M+60.1%

Gross profit$95.6M+67.7%

Operating income-$9.1M+62.9%

Net income-$11.3M+54.9%

EPS (diluted)-$0.09+55.0%

Balance sheet

See full

Cash & equivalents$35.1M-34.7%

Total debt$114.7M+3.5%

Total equity$189.6M+32.9%

Total assets$460.0M+33.7%

Cash flow

See full

Operating cash flow$2.2M+107%

CapEx--100%

Free cash flow$2.2M+107%

Valuation

See full

Market cap$3.29B+57.5%

Profitability

See full

Gross margin90.9%+2.5pp

Operating margin-12%-5.7pp

Net margin-13.9%-6.6pp

FCF margin-52.5%-21.9pp

Returns & leverage

See full

Return on equity-28.2%-13.0pp

Debt / equity0.6×-0.2×

Current ratio2.7×-0.9×

Where this comes from

Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.

net debt/ebitda=12.9×

Based on the most recent quarter.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s net debt / EBITDA?: Arcutis Biotherapeutics, Inc. (ARQT) reported net debt / EBITDA of 12.9× in Q2 2024.
What does net debt / EBITDA mean?: Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.